3.2. Assessment of Differences in the Percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on DCs and Monocytes and the Concentration of Soluble Forms in Serum between GC Patients and Healthy Volunteers. This evidence concerns the gene TLR3 and gastric cancer.